Head-to-head dispatch
Harbor vs NewSelf
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.
Marked down on: Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
Desk Score
NewSelf offers compounded semaglutide+ (with B12/Glycine, from $99.97/mo) and compounded tirzepatide+ (with B6/Glycine, from $144.49/mo).
Marked down on: Not available in Mississippi and Louisiana
FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.
NewSelf takes this head-to-head with the higher Desk Score, 79/100 (C+) against 65/100 (C) for Harbor. Harbor still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Harbor
65/100
C
NewSelf
79/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Harbor | NewSelf |
|---|---|---|
| Semaglutide | $99/mo (starting dose, compounded) | $100/mo (compounded) |
| Tirzepatide | $149/mo (starting dose, compounded) | $144/mo (compounded) |
| Coverage | Coverage not published | 49 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Readers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee. | Readers who want lowest-cost compounded GLP-1 with pharmacy quality transparency. |
| Desk Score | 65/100C | 79/100C+ |
The verdict
Desk pick — NewSelfNewSelf takes this head-to-head with the higher Desk Score, 79/100 (C+) against 65/100 (C) for Harbor. Harbor still holds its ground where its strengths line up with yours.
Choose Harbor if…
Readers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee.
$99/mo (starting dose, compounded) sema · $149/mo (starting dose, compounded) tirz · Coverage not published
Choose NewSelf if…
Readers who want lowest-cost compounded GLP-1 with pharmacy quality transparency.
$100/mo (compounded) sema · $144/mo (compounded) tirz · 49 states
FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Harbor · NewSelf.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Harbor vs CoreAge Rx
- NewSelf vs Vaylen
- Harbor vs Strut Health
- NewSelf vs Ondra Health
- Harbor vs Invigor Medical
- NewSelf vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.